US Archives - Page 30 of 111 - European Medical Journal

Imaging Breakthrough Signals Future for Esophagogastric Prognosis

n a new 5-year follow-up study exploring diagnostic tools for adenocarcinoma of the esophagogastric junction (AEG), PET combined with MRI (PET/MRI) has shown strong potential for predicting long-term survival.

Late-Onset Migraine Aura After 50 Sparks Clinical Questions

Late-onset migraine with aura in patients over 50 is gaining attention as a clinically distinct and underrecognized presentation, according to a new systematic review.

FDA-Cleared Sensor Enhances OSA Treatment: ATS 2025

Clinical trial results for a wearable pulse oximeter and software platform designed to monitor obstructive sleep apnea (OSA) treatment response were presented at the American Thoracic Society (ATS) 2025 International Conference in San Francisco.

Tracking Enterovirus-D68 in Children: New Insights

New findings from a 6-year surveillance study across seven major US academic medical centers reveal that Enterovirus D68 (EV-D68) is capable of causing severe respiratory illness in children regardless of underlying health conditions.

H5N1 in Dairy Cattle Sparks Concern for US Health System

In a critical development for infectious disease experts and healthcare providers across the United States, a new study confirms the emergence of highly pathogenic avian influenza (HPAI) H5N1 in dairy cattle.

AMJ Oncology 2 [Supplement 1] 2025

Prostate cancer progression remains a major challenge in metastatic hormone-sensitive prostate cancer, despite therapeutic advances, and…

Optimal Timing of Rehabilitation in Hand Fracture Recovery

In a landmark systematic review and meta-analysis, researchers have shed new light on the optimal timing for mobilization following open reduction and internal fixation (ORIF) of hand fractures.

New Data Supports Targeted Prurigo Nodularis Therapies

In a significant advancement for the management of prurigo nodularis, a chronic and debilitating skin condition, a new systematic review highlights the promise of emerging biologic and targeted therapies that directly address the disease’s immune and neurogenic drivers.

Pioneering Precision Medicine in Prostate Cancer

Prostate cancer is the second most common cancer and the fifth leading cause of cancer death in males worldwide, with over 1.4 million…

Twitter Study From 2010 to 2023 Reveals Public Confusion Over Dementia Genetic Testing

Public understanding of genetic testing for dementia remains limited and often misinformed, according to a new study analyzing Twitter conversations from 2010 to 2023.